Approval · Notice of Compliance 5877 · 1994
CIPRO: Notice of Compliance 5877
Issued June 8, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5877
- Date
- June 8, 1994
- Company
- Miles Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength, new indication
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRO | 02100533 | Cancelled Post Market |
Medicinal ingredients
- CIPROFLOXACIN HYDROCHLORIDE 100 MG per TAB